Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L12 pseudogene 33 (RPL12P33) is a processed pseudogene related to the RPL12 gene, which encodes a structural protein component of the ribosomal 60S large subunit. As a pseudogene, RPL12P33 is a non-functional genomic DNA sequence similar to the functional RPL12 gene, but it does not encode an active protein product and has no known biological function or disease association. There is no evidence that it serves as a direct therapeutic target or encodes a functional RNA or protein. According to primary gene databases and functional genomics resources, RPL12P33 is a pseudogene, not a protein-coding gene. Pseudogenes do not produce active proteins and are not considered therapeutic targets. The canonical, functional form in this family is "Ribosomal protein L12" (gene: RPL12), which is a structural ribosome component with roles in protein synthesis and possible links to diseases like Diamond-Blackfan anemia. RPL12P33 does not fall into typical target categories such as enzyme, receptor, transporter, or transcription factor. There is no literature or database evidence of interacting drugs, biomarker applications, or known therapeutic safety concerns specific to this pseudogene. If you intended the functional protein (RPL12), refer to "Ribosomal protein L12" for its biological roles. If your interest is in a therapeutic or functional molecule, RPL12P33 is not a correct or actionable target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L12 pseudogene 33 (RPL12P33).